Ximelagatran: An Oral Direct Thrombin Inhibitor for Anticoagulant Therapy

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 503-506

Bentham Science Publishers

Access to resources Recommend Favorite

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

By van Schie Rianne MF   Wadelius Mia   Kamali Farhad   Daly Ann K   Manolopoulos Vangelis G   de Boer Anthonius   Barallon Rita   Verhoef Talitha I   Kirchheiner Julia   Haschke-Becher Elisabeth   Briz Montserrat   Rosendaal Frits R   Redekop William K   Pirmohamed Munir   Maitland-van der Zee Anke-Hilse  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1687-1695

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of coumarinic oral anticoagulants

By Manolopoulos Vangelis G   Ragia Georgia   Tavridou Anna  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 493-496

Future Medicine

Access to resources Recommend Favorite

Patient Self-Monitoring of Oral Anticoagulant Therapy: Potential Benefits and Implications for Clinical Practice

By Douketis J.D.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Self- versus Conventional Management of Oral Anticoagulant Therapy: Effects on INR Variability and Coumarin Dose in a Randomized Controlled Trial

By Thomas Decker Christensen  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 3, 2007-01 ,pp. : 191-197

Adis International

Access to resources Recommend Favorite